Health

Results: 433-444 of 10101

Okomera Strengthens Its Leadership Team With the Appointment of Marion Ghibaudo as Chief Technology Officer

Galderma’s Restylane® Volyme™ Demonstrates High Effectiveness, Satisfaction and a Robust Safety Profile in Chinese Patients With Temple Hollowing

PR Newswire associated0

Skyhawk Therapeutics Announces Final Fifteen-Month Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease Patients

PR Newswire associated0

CordenPharma Appoints Dr. Jean-Luc Herbeaux as Chief Executive Officer to Lead Next Phase of Growth

PR Newswire associated0

Nitinotes Announces First EASE™ Clinical Trial Procedures at Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Italy

Study: Heatwaves Increase Cough Urge, Which Salt Aerosols Reduce

PR Newswire associated0

New Neuroscience Research Challenges Decades-Old Theory Behind Technology Sales Messaging

PR Newswire associated0

ReEmerge, Inc. Exits Stealth with Oversubscribed $37M Series A to Challenge the Limitations of Chronic Cognitive Impairment Caused by Brain Injuries

The IRO platform

Ori Biotech Announces 10-year, $120M Partnership to Advance Automated Manufacturing for Commercial Cell Therapies

Vertex Partners With World Champion Skier Lindsey Vonn to Raise Awareness of JOURNAVX®, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe Acute Pain

NeuroBuds(TM), EarEEG

Cebreo Medical Receives CE Mark for NeuroBuds®, a Discreet In-Ear, Medical-Grade EEG Wearable for Extended Ambulatory Monitoring

Compass Pathways Launches ‘Change the Tune in TRD’ in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 2026